Physician profile
Rodolfo E Saenz
NPI 1538165196
$1,320.74
in general payments reported to CMS, 2019-2025
29 companies · $447 in 2025
The $447 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.49 · 2020: $115 · 2021: $17.41 · 2022: $131 · 2023: $354 · 2024: $159 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $180.61 | 2019-2020 | |
| Aspira Women'S Health INC | $101.33 | 2022-2023 | Ova1 |
| Femselect INC. | $88.45 | 2023 | Enplace |
| Biogen, INC. | $81.80 | 2025 | Zurzuvae |
| Takeda Pharmaceuticals U.S.A., INC. | $69.61 | 2024-2025 | Entyvio |
| Merck Sharp & Dohme LLC | $56.01 | 2020-2025 | Gardasil 9, Capvaxive |
| Minerva Surgical, INC | $54.33 | 2024-2025 | |
| Pfizer INC. | $50.07 | 2021-2025 | |
| Hologic Sales and Service, LLC | $45.76 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Avanos Medical | $44.34 | 2022-2023 | On-Q* Pump and Accessories |
| Exact Sciences Corporation | $44.03 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $43.53 | 2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $42.55 | 2025 | Wavewriter Alpha Prime 16 |
| Ethicon US, LLC | $39.43 | 2022-2023 | Monocryl, Dermabond Prineo, Vicryl |
| Organon LLC | $35.97 | 2023-2024 | Nexplanon |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $35.62 | 2023 | Interstim |
| Abbvie INC. | $32.91 | 2024-2025 | |
| Redhill Biopharma INC. | $30.80 | 2023 | Talicia |
| Irhythm Technologies, INC. | $27.32 | 2023 | Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.57 | 2024 | Lifevest |
| Janssen Biotech, INC. | $25.25 | 2025 | Simponi, Simponi Aria, Stelara |
| Novo Nordisk INC | $23.23 | 2025 | Rybelsus, Ozempic |
| Mayne Pharma Commercial LLC | $22.43 | 2024 | |
| Myriad Women'S Health, INC. | $21.18 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.61 | 2023 | Jardiance |
| Coopersurgical, INC. | $20.57 | 2023 | Paragard T 380a |
| Astellas Pharma US INC | $19.82 | 2023 | Veozah |
| Sumitomo Pharma America, INC. | $16.91 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Saenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.